Detection of Viral and Bacterial Respiratory Pathogens Identified by Molecular Methods in COVID-19 Hospitalized Patients and Its Impact on Mortality and Unfavorable Outcomes.
Alonso Ricardo Soto-TarazonaDante M Quiñones-LaverianoFaviola ValdiviaEduardo Juscamayta-LópezJohan Alexander Azañero-HaroLiliana ChambiHelen HornaGladys PatiñoElizabet GuzmanJhony Alberto De La Cruz-VargasPublished in: Infection and drug resistance (2021)
A high frequency of respiratory pathogens was detected by molecular methods in patients with COVID-19 pneumonia but were not associated with unfavorable outcomes. No atypical agents or influenza virus were found. The high use antibiotics before admission is a concern. Our data suggest that the use of drug therapy against atypical bacteria and viruses would not be justified in patients hospitalized for COVID-19.
Keyphrases
- high frequency
- sars cov
- coronavirus disease
- transcranial magnetic stimulation
- end stage renal disease
- newly diagnosed
- emergency department
- gram negative
- chronic kidney disease
- prognostic factors
- stem cells
- antimicrobial resistance
- single molecule
- peritoneal dialysis
- cardiovascular events
- risk factors
- electronic health record
- patient reported outcomes
- respiratory tract
- cardiovascular disease
- intensive care unit
- coronary artery disease
- weight loss
- insulin resistance